Date: Tuesday, July 22nd, 2025
Time: 1:00pm – 2:00pm ET

WEBINAR TOPIC:

Review the clinical benefits of wilate®, highlighting the benefits vs current vWD therapies.

OBJECTIVES:

1. Understand the attributes of wilate® for vWD: 1:1 ratio which mimics the physiologic activity of vWF and FVIII and the synchronous decay curves, which facilitates factor activity monitoring.
2. Understand the absence of vWF or FVIII accumulation when using wilate® during surgery and prophylaxis.
3. Review the only product approved for children older than 6 years and adults with any type of vWD and under any clinical circumstance.

AUDIENCE:

All HTC Staff

SPEAKER:

Claudio Sandoval, Senior Director of Scientific & Medical Affairs at Octapharma

Claudio Sandoval is the Senior Director of Scientific & Medical Affairs at Octapharma. Before his current role he was a pediatric hematologist-oncologist for 30 years caring for children with bleeding disorders, cancer, sickle cell disease, and other maladies. Claudio graduated from New York Medical College and trained at Schneider Children’s Hospital in New Hyde Park, NY and St. Jude Children’s Research Hospital in Memphis, TN.